![]() |
市場調查報告書
商品編碼
1700090
腦電圖設備市場預測至 2032 年:按產品類型、設備類型、應用、最終用戶和地區進行的全球分析Electroencephalography Devices Market Forecasts to 2032 - Global Analysis By Product Type, Device Type, Application and End User and By Geography |
根據 Stratistics MRC 的數據,全球腦電圖測量設備市場預計在 2025 年達到 15 億美元,到 2032 年將達到 32 億美元,預測期內的複合年成長率為 11.8%。
腦電圖儀是醫療設備。它透過放置在頭皮上的電極來檢測腦電波模式,並有助於診斷癲癇、睡眠障礙和腦損傷等神經系統疾病。 EEG 設備範圍從可攜式到臨床級,對於監測大腦功能和評估研究、神經病學和認知研究中的神經活動異常至關重要。
根據美國疾病管制與預防中心(CDC)的數據,到2022年,美國將有超過510萬人患有癲癇病史,目前有340萬人受到影響。
神經系統疾病盛行率不斷上升
癲癇、阿茲海默症和帕金森氏症等神經系統疾病的盛行率不斷上升,是腦電圖設備需求的主要促進因素。此外,老年人口的增加和對早期診斷的認知的提高也促進了市場的成長。此外,腦電圖技術的進步使得非侵入性診斷更具吸引力,並成為監測腦部活動的首選方案。預計這一趨勢將持續下去,有助於擴大市場。
開發中地區的准入受限
新興市場對先進腦電圖技術的取得有限阻礙了市場的成長。高成本和不足的醫療基礎設施阻礙了這些地區的投資。此外,腦電圖服務的限制性報銷政策進一步限制了其採用。小型醫院和診所通常缺乏購買和維護複雜腦電圖系統的資源,阻礙了其廣泛應用。
人工智慧和機器學習整合
人工智慧和機器學習在腦電圖分析中的整合代表著巨大的市場成長機會。這些技術將提高診斷準確性、提供預測洞察力並推動個人化醫療的創新。此外,人工智慧主導的腦電圖系統可以自動解釋資料,減少對專業知識的需求。此外,策略合作和研究資金對於利用這些機會和促進更複雜的 EEG 設備的開發至關重要。
與替代神經影像技術的競爭
EEG 機器面臨來自 MRI、CT 和 PET 掃描等先進神經成像工具的競爭,這些工具為大腦結構評估提供了高空間解析度。儘管 EEG 具有良好的時間解析度並且具有成本效益,但單獨使用它會帶來挑戰,因為在複雜情況下更傾向於使用多模式診斷。此外,增加對替代技術的研發投入可能會分散注意力,需要持續創新才能維持 EEG 系統的相關性。
COVID-19 疫情凸顯了包括腦電圖機在內的遠端監控技術的重要性。然而,供應鏈中斷和預算限制最初減緩了市場成長。隨著經濟復甦,對遠端醫療和家庭監控解決方案的關注度不斷提高,腦電圖市場也因此受益。此外,疫情加速了數位健康技術的採用,為腦電圖設備的長期成長奠定了基礎。
醫院和診所部門預計在預測期內將實現最大幅度成長
由於患者數量多、基礎設施先進、人力熟練,預計醫院和診所部門將在預測期內佔據最大的市場佔有率。在優惠報銷政策的支持下,這些環境利用 EEG 進行關鍵診斷、手術監測和研究。此外,與學術機構合作進行臨床試驗增強了我們在該領域的領導地位。由於強大的醫療保健框架和神經系統疾病盛行率的上升,美國在醫院腦電圖應用方面處於領先地位。
穿戴式裝置領域預計將在預測期內實現最高複合年成長率
受家庭監測和慢性病管理需求的推動,穿戴式裝置領域預計將在預測期內實現最高成長率。輕巧的無線設計提高了患者的舒適度並實現了長期資料收集。此外,與智慧型手機和物聯網平台的整合將支援即時分析,對消費者和臨床醫生都具有吸引力。專注於治療癲癇和睡眠障礙的穿戴式設備的新興企業正在推動創新,並為該行業的快速擴張做好準備。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其先進的醫療保健系統、高額的研發投入以及 Natus Medical 和 Cadwell Industries 等主要企業的強大影響力。神經系統疾病的高盛行率和保險覆蓋率將進一步推動需求。此外,FDA 對人工智慧增強型腦電圖設備的核准以及政府對腦研究的資助正在幫助該市場保持主導地位。
預計亞太地區在預測期內將呈現最高的複合年成長率,這得益於醫療保健服務的改善、人們對神經系統疾病的認知不斷提高以及醫療旅遊業的擴大。印度和中國等國家正在投資現代化診斷技術,而日本的人口老化也推動了需求。此外,與當地製造商以及提供具有成本效益的 EEG 系統的全球公司的合作正在加速市場滲透,使該地區成為高成長中心。
According to Stratistics MRC, the Global Electroencephalography Devices Market is accounted for $1.5 billion in 2025 and is expected to reach $3.2 billion by 2032 growing at a CAGR of 11.8% during the forecast period. Electroencephalography (EEG) devices are medical instruments used to measure and record electrical activity in the brain. They detect brain wave patterns through electrodes placed on the scalp, aiding in diagnosing neurological conditions like epilepsy, sleep disorders, and brain injuries. EEG devices range from portable to clinical-grade systems and are essential in research, neurology, and cognitive studies for monitoring brain function and assessing abnormalities in neural activity.
According to the Centers for Disease Control and Prevention (CDC), in 2022, over 5.1 million people in the U.S. had a history of epilepsy, with 3.4 million currently affected.
Increasing prevalence of neurological disorders
The rising incidence of neurological conditions such as epilepsy, Alzheimer's, and Parkinson's disease significantly drives the demand for EEG devices. Furthermore, the growing geriatric population and increased awareness about early diagnosis contribute to market growth. Additionally, advancements in EEG technology enhance its appeal for non-invasive diagnostics, making it a preferred choice for monitoring brain activity. This trend is expected to continue, bolstering the market's expansion.
Limited access in developing regions
Limited access to advanced EEG technology in developing regions hinders market growth. High costs and inadequate healthcare infrastructure discourage investments in these areas. Moreover, restricted reimbursement policies for EEG services further limit adoption. Smaller hospitals and clinics often lack the resources to purchase and maintain sophisticated EEG systems, creating barriers to widespread adoption.
Integration of Ai and machine learning
The integration of AI and machine learning in EEG analysis presents significant opportunities for market growth. These technologies enhance diagnostic accuracy and enable predictive insights, fostering innovation in personalized medicine. Furthermore, AI-driven EEG systems can automate data interpretation, reducing the need for specialized expertise. Additionally, strategic collaborations and research funding are crucial for capitalizing on these opportunities, driving the development of more sophisticated EEG devices.
Competition from alternative neuroimaging techniques
EEG devices face competition from advanced neuroimaging tools like MRI, CT, and PET scans, which offer higher spatial resolution for structural brain assessments. While EEG excels in temporal resolution and cost-effectiveness, preference for multi-modal diagnostics in complex cases challenges its standalone use. Additionally, rising R&D investments in alternative technologies may divert focus, necessitating continuous innovation in EEG systems to maintain relevance.
The COVID-19 pandemic highlighted the importance of remote monitoring technologies, including EEG devices. However, supply chain disruptions and budget constraints initially slowed market growth. As economies recover, the focus on telehealth and home-based monitoring solutions has increased, benefiting the EEG market. Furthermore, the pandemic accelerated the adoption of digital health technologies, positioning EEG devices for long-term growth.
The hospitals and clinics segment is expected to be the largest during the forecast period
The hospitals and clinics segment is expected to account for the largest market share during the forecast period, due to high patient footfall, advanced infrastructure, and skilled personnel. These settings utilize EEG for critical diagnoses, surgical monitoring, and research, supported by favorable reimbursement policies. Additionally, partnerships with academic institutions for clinical trials reinforce segment leadership. The U.S. led in hospital-based EEG adoption, driven by robust healthcare frameworks and rising neurological disorder prevalence.
The wearable devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the wearable devices segment is predicted to witness the highest growth rate, fueled by demand for home-based monitoring and chronic disease management. Lightweight, wireless designs enhance patient comfort, enabling long-term data collection. Moreover, integration with smartphones and IoT platforms supports real-time analytics, appealing to both consumers and clinicians. Startups focusing on epilepsy and sleep disorder wearables drive innovation, positioning this segment for rapid expansion.
During the forecast period, the North America region is expected to hold the largest market share, due to advanced healthcare systems, high R&D investments, and strong presence of key players like Natus Medical and Cadwell Industries. High neurological disorder prevalence and insurance coverage further propel demand. Additionally, FDA approvals for AI-enhanced EEG devices and government funding for brain research sustain market dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving healthcare access, rising neurological disease awareness, and expanding medical tourism. Countries like India and China invest in modernizing diagnostics, while Japan's aging population boosts demand. Furthermore, local manufacturers offering cost-effective EEG systems and partnerships with global firms accelerate market penetration, positioning the region as a high-growth hub.
Key players in the market
Some of the key players in Electroencephalography Devices Market include Natus Medical Incorporated, Medtronic plc, Nihon Kohden Corporation, Cadwell Industries, Inc., NeuroWave Systems Inc., Electrical Geodesics, Inc. (EGI), Compumedics Limited, Koninklijke Philips N.V., GE Healthcare, Advanced Brain Monitoring, Inc., Brain Products GmbH, BioSemi, Emotiv, NeuroSky, g.tec medical engineering GmbH, ANT Neuro, Cephalon A/S and Noraxon U.S.A., Inc.
In January 2025, Brain Products released BrainVision Recorder 1.27.0001 and BrainVision Recorder for CGX 2.01.0102.
In January 2025, Emotiv, a global leader in EEG technology, announces its next-generation EEG Active Noise-Cancelling Earphones. These smart earphones enhance personal wellness by integrating advanced EEG technology to provide insights into cognitive performance and overall well-being-alongside exceptional sound quality.
In January 2024, Compumedics Limited is pleased to announce new MEG orders from Tsinghua and Tianjin Universities in China. These sales are via Compumedics' long-term Chinese distributor and partner, Beijing Fistar. The MEG systems, along with a host of peripherals including simultaneous EEG, stimulators, computers, and CURRY neuroimaging software, will ship to both sites in 2025. One order is for two single-helmet MEG systems, and the other is for a dual-helmet MEG system. Both will be configured for hyperscanning.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.